The Life Plan (73 page)
Authors: Jeffry Life
Tags: #Men's Health, #Aging, #Health & Fitness, #Exercise, #Self-Help
Caloric index
An updated listing of age management medicine physicians across the country
And much more
References
On Hypnosis
1. Coué, Emile.
Self Mastery Through Conscious Autosuggestion.
London: Allen & Unwin, 1959.
2. Boyne, Gil.
Transforming Therapy: A New Approach to Hypnotherapy.
Glendale, Calif.: Westwood, 1989.
3. Simmerman, Tim.
Fundamentals of Hypnotism.
1996. American Council of Hypnotist Examiners Approved.
On Testosterone
1. Annewieke, W. van den Beld, Frank H. de Jong, et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
Journal of Clinical Endrocrinology & Metabolism
. Vol. 85, No. 9, 3276–82. 2000.
2. Bross, R., Javanbakht, M., and Bhasin, S. Anabolic interventions for aging-associated sarcopenia.
J Clin Endocrinol Metab.
Vol. 84, No. 10, 3420–30. 1999.
3. Tenover, J. S. Effects of testosterone supplementation in the aging male.
J Clin Endocrinol Metab.
1992 Oct.; 75(4):1092–8.
4. Shalender, B., and Tenover, J. S. Age-Associated Sarcopenia—Issues in the use of testosterone as an anabolic agent in older men.
J Clin Endocrinol Metab.
Vol. 82, No. 6, 1659–60. 1997.
5. Urban, R. J., Bodenbrug, Y. H., et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis.
American Journal of Physiology.
1995 Nov.; 269 (5 Pt 1):E820–6.
6. Snyder, P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
International Journal of Obesity and Related Metabolic Disorders.
1992 Dec.; 16(12):991–7.
7. Snyder, P., Peachey, H., Hannoush, P., et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age.
J Clin Endocrinol Metab.
Vol. 84, No. 6, 1966–72. 1999.
8. Marin, P., Holmang, S., Jonsson, L., Sjostrom, L., Kvist, H., et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Int J Obes Relat Metab Disord.
1992 Dec.; 16(12):991–7.
9. Sundeep, Khosla, Melton, L. Joseph III, and Elizabeth, J. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen.
J Clin Endocrinol Metab.
Vol. 83, No. 7, 2266–74. 1998.
10. Chute, G. Sex hormones and coronary artery disease.
American Journal of Medicine.
1987 Nov.; 83(5):853–9.
11. Khaw, K. T., and Barrett-Connor, E. Lower endogenous androgens predict central adiposity in men.
Annals of Epidemiology.
1992 Sep.; 2(5):675–82.
12. Khaw, K. T., and Barrett-Connor, E. Blood pressure and endogenous testosterone in men: an inverse relationship.
Journal of Hypertension.
1988 Apr.; 6(4):329–32.
13. Marin, P., Krotkiewski, M., and Bjorntorp, P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
European Journal of Medicine.
1992 Oct.; 1(6):329–36.
14. Zmuda, J. M., Cauley, J. A., Kriska, A., Glynn, N. W., Gutai, J. P., and Kuller, L. H. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants.
American Journal of Epidemiology.
1997 Oct. 15; 146(8):609–17.
15. English, K. M., Mandour, O., Steeds, R. P., Diver, M. J., Jones, T. H., and Channer, K. S. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.
European Heart Journal.
2000 Jun.; 21(11):890–4.
16. English, K. M., Steeds, R. P., Jones, T. H., Diver, M. J., and Channer, K. S. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study.
Circulation.
2000 Oct. 17; 102(16):1906–11.
17. Wu, S. Z., and Weng, X. Z. Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients.
China Medical Journal (Engl).
1993 Jun.; 106(6):415–8.
18. Webb, C. M., Adamson, D. L., de Zeigler, D., and Collins, P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease.
American Journal of Cardiology.
1999 Feb. 1; 83(3):437–9, A9.
19. Muller, M. Endogenous sex hormones and cardiovascular disease in men.
J Clin Endocrinol Metab.
Vol. 88, No. 11, 5076–86. 2003.
20. Muller, M., Grobbee, D. E., den Tonkelaar, I., Lamberts, S. W., and van der Schouw, Y. T. Endogenous sex hormones and metabolic syndrome in aging men.
J Clin Endocrinol Metab.
2005 May; 90(5):2618–23.
21. Rupprecht, R. Neuroactive steroids: Mechanisms of action and neuropsychopharmacological properties.
Psychoneuroendocrinology.
2003 Feb.; 28(2):139–68.
22. Moffat, S. D., et al. Free testosterone and risk for Alzheimer disease in older men.
Neurology.
2004 Jan. 27; 62(2):188–93.
23. Gouras, G. K., Xu, H., Gross, R. S., et al. Testosterone reduces neuronal secretion of Alzheimer’s β-amyloid peptides.
Proceedings of the National Academy of Sciences of the United States of America.
2000; 97:1202–5.
24. Papasozomenos, S. Ch., and Shanavas, A. Testosterone prevents the heat shock–induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: Implications for Alzheimer’s disease.
Proc Natl Acad Sci USA.
2002 Feb. 5; 99(3):1140–5.
25. Gillett, M. J., Martins, R. N., Clarnette, R. M., Chubb, S. A., Bruce, D. G., and Yeap, B. B. Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia.
American Journal of Alzheimer’s Disease.
2003 Aug.; 5(4):267–9.
26. Tan, R. S., and Pu, S. J. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer’s disease.
Aging Male.
2003 Mar.; 6(1):13–17.
27. Hogervorst, E., Combrinck, M., et al. Testosterone and gonadotropin levels in men with dementia.
Neuroendocrinology Letters.
2003; 24(3–4):203–8.
28. Hogervorst, E., Bandelow, S., Combrinck, M., and Smith, A. D. Low free testosterone is an independent risk factor for Alzheimer’s disease.
Experimental Gerontology.
2004 Nov.–Dec.; 39(11–12):1633–9.
29. Paoletti, A. M., et al. Low androgenization index in elderly women and elderly men with Alzheimer’s disease.
Neurology.
2004 Jan. 27; 62(2):301–3.
30. Ramzi, R. Hajjar, Kaiser Fran E., and Morley, John E. Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis.
J Clin Endocrinol Metab.
1997 Vol. 82, No. 11, 3793–96.
31. Kwan, M., Greenleaf, W. J., Mann, J., Crapo, L., and Davidson, J. M. The nature of androgen action on male sexuality: A combined laboratory-self-report study on hypogonadal men.
J Clin Endocrinol Metab.
1983 Vol. 57, 557–62.
32. Skakkebaek, N. E., Bancroft, J., Davidson, D. W., and Warner, P. Androgen replacement with oral testosterone undecenoate in hypogonadal men: A double blind controlled study.
Clinical Endocrinology (Oxf).
1981 Jan.; 14:49–61.
33. O’Carroll, R., and Bancroft, J. Testosterone therapy for low sexual interest and erectile dysfunction in men: A controlled study.
British Journal of Psychiatry.
1984 Aug.; 145:146–51.
34. Ebert, T., Jockenhovel, F., Morales, A., et al. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
European Urology.
2005 Feb.; 47(2):137–46.
35. Carani, C., Zini, D., Baldini, A., et al. Effects of androgen treatment in impotent men with normal and low levels of free testosterone.
Archives of Sexual Behavior.
1990 Jun.; 19(3):223–34.
36. Jain, J. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men.
Journal of Urology.
1998 Feb.; 159(2):441–3.
37. Cooper, C. S., Perry, P. J., Sparks, et al. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men.
J Urol.
1998 Feb.; 159(2):441–3.
38. Margolese, H. C. The male menopause and mood: Testosterone decline and depression in the aging male—is there a link?
Journal of Geriatric Psychiatry and Neurology.
2000 Summer; 13(2):93–101.
39. Morley, J. E. Testosterone replacement and the physiologic aspects of aging in men.
Mayo Clinic Proceedings.
2000 Jan.; 75 Suppl:S83–7.
40. Basaria, Shehzad, Wahlstrom, Justin T., and Dobs, Adrian S. Anabolic-androgenic steroid therapy in the treatment of chronic diseases.
J Clin Endocrinol Metab.
Vol. 86, No. 11, 5108–17. 2001.
41. Hoffman, M. A., DeWolf, W. C., and Morgentaler, A. Is low serum free testosterone a marker for high grade prostate cancer?
J Urol.
2000 Mar.; 163(3):824–7.
42. Asbell, S. O., Raimane, K. C., Montesano, A. T., Zeitzer, K. L., Asbell, M. D., and Vijayakumar, S. Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients.
Journal of the National Medical Association.
2000 Sep.; 92(9):445–9.
43. Rhoden, E. L., and Morgentaler, A. Risks of testosterone-replacement therapy and recommendations for monitoring.
New England Journal of Medicine.
2004 Jan. 29; 350(5):482–92.
44. Carter, H. B., et al. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.
Prostate.
1995 Jul.; 27(1):25–31.
45. Conway, H. J. Randomized clinical trial of testosterone replacement therapy in hypogonadal men.
International Journal of Andrology.
1988 Aug.; 11(4):247–64.
46. Pugh, Peter, Jones, T. Hugh, and Channer, Kevin. Acute haemodynamic effects of testosterone in men with chronic heart failure.
Eur Heart J.
2003, 24, 909–15.
47. Caminiti, Guiseppe, Volterrani, Maurizio, et al. Effect of long-acting testosterone treatment on function exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: A double-blind, placebo controlled, randomized study.
J Am Coll. Cardiol.
Other books
A Court of Mist and Fury by Sarah J. Maas
Yearning For Her Curves: (A BWWM Interracial Romance) by Stone, Nora
Mugged by Ann Coulter
Barred by Walker, Paisley
50 Reasons People Give for Believing in a God by Guy P. Harrison
Shadow's Witness by Kemp, Paul
The Company Town by Hardy Green
Fade To Midnight by Shannon McKenna
My Stroke of Insight: A Brain Scientist's Personal Journey by Jill Bolte Taylor
Final Surrender by Jennifer Kacey